-
Something wrong with this record ?
Fate of the capping agent of biologically produced gold nanoparticles and adsorption of enzymes onto their surface
P. Pourali, V. Dzmitruk, M. Pátek, E. Neuhöferová, M. Svoboda, V. Benson
Language English Country England, Great Britain
Document type Journal Article
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
Nature Open Access
from 2011-12-01
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
Springer Nature OA/Free Journals
from 2011-12-01
- MeSH
- Adsorption MeSH
- Endopeptidase K MeSH
- Metal Nanoparticles * chemistry MeSH
- Ribonuclease, Pancreatic MeSH
- Gold * chemistry MeSH
- Publication type
- Journal Article MeSH
Enzymotherapy based on DNase I or RNase A has often been suggested as an optional strategy for cancer treatment. The efficacy of such procedures is limited e.g. by a short half-time of the enzymes or a low rate of their internalization. The use of nanoparticles, such as gold nanoparticles (AuNPs), helps to overcome these limits. Specifically, biologically produced AuNPs represent an interesting variant here due to naturally occurring capping agents (CA) on their surface. The composition of the CA depends on the producing microorganism. CAs are responsible for the stabilization of the nanoparticles, and promote the direct linking of targeting and therapeutic molecules. This study provided proof of enzyme adsorption onto gold nanoparticles and digestion efficacy of AuNPs-adsorbed enzymes. We employed Fusarium oxysporum extract to produce AuNPs. These nanoparticles were round or polygonal with a size of about 5 nm, negative surface charge of about - 33 mV, and maximum absorption peak at 530 nm. After the adsorption of DNAse I, RNase A, or Proteinase K onto the AuNPs surface, the nanoparticles exhibited shifts in surface charge (values between - 22 and - 13 mV) and maximum absorption peak (values between 513 and 534 nm). The ability of AuNP-enzyme complexes to digest different targets was compared to enzymes alone. We found a remarkable degradation of ssDNA, and dsDNA by AuNP-DNAse I, and a modest degradation of ssRNA by AuNP-RNase A. The presence of particular enzymes on the AuNP surface was proved by liquid chromatography-mass spectrometry (LC-MS). Using SDS-PAGE electrophoresis, we detected a remarkable digestion of collagen type I and fibrinogen by AuNP-proteinase K complexes. We concluded that the biologically produced AuNPs directly bound DNase I, RNase A, and proteinase K while preserving their ability to digest specific targets. Therefore, according to our results, AuNPs can be used as effective enzyme carriers and the AuNP-enzyme conjugates can be effective tools for enzymotherapy.
Institute of Analytical Chemistry Czech Academy of Sciences 602 00 Brno Czech Republic
Institute of Microbiology Czech Academy of Sciences 142 20 Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23003749
- 003
- CZ-PrNML
- 005
- 20230425140849.0
- 007
- ta
- 008
- 230418s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-023-31792-5 $2 doi
- 035 __
- $a (PubMed)36966192
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Pourali, Parastoo $u Institute of Microbiology, Czech Academy of Sciences, 142 20, Prague, Czech Republic
- 245 10
- $a Fate of the capping agent of biologically produced gold nanoparticles and adsorption of enzymes onto their surface / $c P. Pourali, V. Dzmitruk, M. Pátek, E. Neuhöferová, M. Svoboda, V. Benson
- 520 9_
- $a Enzymotherapy based on DNase I or RNase A has often been suggested as an optional strategy for cancer treatment. The efficacy of such procedures is limited e.g. by a short half-time of the enzymes or a low rate of their internalization. The use of nanoparticles, such as gold nanoparticles (AuNPs), helps to overcome these limits. Specifically, biologically produced AuNPs represent an interesting variant here due to naturally occurring capping agents (CA) on their surface. The composition of the CA depends on the producing microorganism. CAs are responsible for the stabilization of the nanoparticles, and promote the direct linking of targeting and therapeutic molecules. This study provided proof of enzyme adsorption onto gold nanoparticles and digestion efficacy of AuNPs-adsorbed enzymes. We employed Fusarium oxysporum extract to produce AuNPs. These nanoparticles were round or polygonal with a size of about 5 nm, negative surface charge of about - 33 mV, and maximum absorption peak at 530 nm. After the adsorption of DNAse I, RNase A, or Proteinase K onto the AuNPs surface, the nanoparticles exhibited shifts in surface charge (values between - 22 and - 13 mV) and maximum absorption peak (values between 513 and 534 nm). The ability of AuNP-enzyme complexes to digest different targets was compared to enzymes alone. We found a remarkable degradation of ssDNA, and dsDNA by AuNP-DNAse I, and a modest degradation of ssRNA by AuNP-RNase A. The presence of particular enzymes on the AuNP surface was proved by liquid chromatography-mass spectrometry (LC-MS). Using SDS-PAGE electrophoresis, we detected a remarkable digestion of collagen type I and fibrinogen by AuNP-proteinase K complexes. We concluded that the biologically produced AuNPs directly bound DNase I, RNase A, and proteinase K while preserving their ability to digest specific targets. Therefore, according to our results, AuNPs can be used as effective enzyme carriers and the AuNP-enzyme conjugates can be effective tools for enzymotherapy.
- 650 12
- $a zlato $x chemie $7 D006046
- 650 12
- $a kovové nanočástice $x chemie $7 D053768
- 650 _2
- $a adsorpce $7 D000327
- 650 _2
- $a pankreatická ribonukleasa $7 D012259
- 650 _2
- $a endopeptidasa K $7 D019286
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dzmitruk, Volha $u Center of Molecular Structure, Institute of Biotechnology, Czech Academy of Sciences, 252 50, Prague, Czech Republic
- 700 1_
- $a Pátek, Miroslav $u Institute of Microbiology, Czech Academy of Sciences, 142 20, Prague, Czech Republic
- 700 1_
- $a Neuhöferová, Eva $u Institute of Microbiology, Czech Academy of Sciences, 142 20, Prague, Czech Republic
- 700 1_
- $a Svoboda, Milan $u Institute of Analytical Chemistry, Czech Academy of Sciences, 602 00, Brno, Czech Republic
- 700 1_
- $a Benson, Veronika $u Institute of Microbiology, Czech Academy of Sciences, 142 20, Prague, Czech Republic. benson@biomed.cas.cz
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 13, č. 1 (2023), s. 4916
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36966192 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425140846 $b ABA008
- 999 __
- $a ok $b bmc $g 1924431 $s 1189958
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 13 $c 1 $d 4916 $e 20230325 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20230418